ImmuKyne Protein Array

The ImmuKyne™ protein array allows for simultaneous screening of autoantibodies to over 300 autoantigens comprising clinically significant protein classes such as cytokines, interleukins and other immunomodulatory proteins.

Leveraging on the patented Sengenics KREX™ functional proteomics technology ensures that all proteins on the ImmuKyne™ protein array are full-length, correctly folded and functional with both conformational and non-conformational epitopes preserved.

Key applications:

  • Distinguish individuals at elevated risk of developing ARDS or other severe complications of COVID-19 disease and may correspond to underlying aetiologies.
  • Large-scale autoantibody profiling (aAb-p) of patients who have succumbed to COVID-19 and those who have recovered.
  • Identification of disease complication sub-types for high-risk patients.


Protein Array

sero-profiling platform

Protein Array

Screening of
cancer-testis antigens

OncoREX p53
Cancer Array

Cancer drug
screening and discovery

Protein Array

Flexible format for
high-throughput screening

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. The key application of KREX is the discovery of autoantibody biomarkers for two core medical use cases:  stratification of patients undergoing treatment with autoimmune or cancer drugs and identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Find Us On:

2008 – 2020© Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361